Contact Us

Request a Demo

Condition

Hodgkin's Disease(1)

Multiple Myeloma(1)

Non Hodgkin's Lymphoma(1)

Overall Status

Completed(1)

Phase

phase 2(1)

Sponsor New

Genzyme, a Sanofi Company(1)

Intervention New

can be any registered nonpegylated form of g-csf(1)

plerixafor (amd3100)(1)

Study Results

Has Results

Study Documents

Intervention Type

drug(1)

Funder Type

Industry(1)

Study Type

Interventional(1)

Age Group

Any

Youth (0 - 17 years)

Adult (18 - 64 years)

Older Adult (65+ years)

Gender

all(1)

City

Non Hodgkin's Lymphoma Clinical Trials in Berlin

Create an account to Download

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

G

Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). - 2009

Completed

Lymphoma
+3 more

Plerixafor (AMD3100)
Can be any registered nonpegylated form of G-CSF

Berlin, Germany
+4 more

2014-02-10

Feb 10, 2014

Do More

Create up to 2 groups of studies for comparison and sharing
Get notified when studies are updated
Download tabulated search results instantly
Unlimited searches

Sign UpNot Today

2022 © Clincosm, Inc.

Exploring the universe of clinical trials just got cosmically easier.

Newest Clinical Trials